Jefferies Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,000
Closed -$1.64M 1713
2025
Q4
$1.64M Hold
5,000
0.01% 889
2025
Q3
$1.41M Hold
5,000
0.01% 761
2025
Q2
$1.4M Buy
+5,000
New +$1.42M 0.01% 625
2025
Q1
Sell
-55,300
Closed -$14.4M 1592
2024
Q4
$14.4M Sell
55,300
-6,200
-10% -$1.84M 0.09% 174
2024
Q3
$19.8M Buy
61,500
+4,400
+8% +$1.44M 0.14% 92
2024
Q2
$17.8M Buy
57,100
+33,700
+144% +$9.9M 0.19% 90
2024
Q1
$6.65M Buy
23,400
+19,400
+485% +$5.68M 0.06% 239
2023
Q4
$1.15M Hold
4,000
0.01% 892
2023
Q3
$1.08M Sell
4,000
-19,500
-83% -$4.87M 0.01% 814
2023
Q2
$5.22M Sell
23,500
-39,800
-63% -$9.24M 0.05% 344
2023
Q1
$15.3M Buy
63,300
+41,600
+192% +$10.2M 0.12% 141
2022
Q4
$5.7M Buy
+21,700
New +$5.82M 0.04% 366

Other funds holding AMGN

Jefferies Financial Group's AMGN Position: Q1 2026 in Review

Jefferies Financial Group increased its Amgen (AMGN) stake by 3.7% in Q1 2026, buying an estimated $1.39M and bringing the position to 108,330 shares worth $38.1M. The position accounts for 0.26% of the portfolio, ranked #65.

Jefferies Financial Group first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $130M in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Jefferies Financial Group held 108,330 shares of Amgen worth $38.1M as of Q1 2026.
  • Jefferies Financial Group bought 3,893 Amgen shares in Q1 2026, an estimated $1.39M.
  • Amgen made up 0.26% of Jefferies Financial Group's portfolio in Q1 2026, its #65 holding.
  • Jefferies Financial Group first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Amgen position peaked at $130M in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.